Since Huggins and Hodges demonstrated the responsiveness of prostate cancer to
androgen deprivation therapy (ADT), androgen‐suppressing strategies have formed the …

In benign prostatic hyperplasia (BPH) there will be a sudden impact on overall quality of life
of patient. This disease occurs normally at the age of 40 or above and also is associated …

OBJECTIVES: To determine the expression of prostate-specific membrane antigen (PSMA)
before and after androgen-deprivation therapy and to compare PSMA expression with …

Purpose: To evaluate the clinical outcomes of 48 Gy of three-dimensional stereotactic
radiotherapy in four fractions for treating Stage I lung cancer using a stereotactic body frame …

Purpose: To report the acute and late toxicity and preliminary biochemical outcomes in 772
patients with clinically localized prostate cancer treated with high-dose intensity-modulated …

Purpose: Three-dimensional conformal radiation therapy (3D-CRT) is a technique designed
to deliver prescribed radiation doses to localized tumors with high precision, while effectively …

Purpose: We present the long-term outcome and tolerance of 3-dimensional (D) conformal
and intensity modulated radiation therapy for localized prostate cancer. Materials and …

Purpose: To compare acute and late toxicities of high-dose radiation for prostate cancer
delivered by either conventional three-dimensional conformal radiation therapy (3D-CRT) or …

Purpose: To test the hypothesis that androgen ablation before and during radiotherapy for
locally advanced carcinoma of the prostate may, by reducing tumor bulk and enhancing …

PURPOSE: To compare the prostate-specific antigen (PSA) relapse-free survival outcome
and incidence of late toxicity for patients with early-stage prostate cancer treated at a single …